Professor in Pathology and Molecular Clinical Microbiology, Nanchang Joint Programme
CAISE SBBS Lead
Publications

Publications of specific relevance to academic inclusion in science and engineering
2021
De Falco G, Gibellini D, Piccaluga PP, Murray PG and Mbulaiteye S (2021).
Editorial: Molecular Mechanisms of Pathogen-Driven Infectious and Neoplastic Diseases. Frontiers Frontiers in Cell and Developmental Biology vol. 9,
10.3389/fcell.2021.6961522018
De Falco G (2018).
Current understanding of the role and regulation
of miRNAs in Burkitt lymphoma. Dove Medical Press Blood and Lymphatic Cancer : Targets and Therapy 10.2147/BLCTT.S1296182017

Mundo L, Ambrosio MR, Picciolini M, Lo Bello G, Gazaneo S, Del Porro L, Lazzi S, Navari M, Onyango N, Granai M, Bellan C,
De Falco G, Gibellini D, Piccaluga PP and Leoncini L (2017).
Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases. Front Microbiol vol. 8, 229-229.
10.3389/fmicb.2017.002292015

Amato T, Abate F, Piccaluga P, Iacono M, Fallerini C, Renieri A,
De Falco G, Ambrosio MR, Mourmouras V, Ogwang M, Calbi V, Rabadan R, Hummel M, Pileri S, Leoncini L and Bellan C (2015).
Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma. Oxford University Press (Oup) American Journal of Clinical Pathology vol. 145, (1) 116-127.
10.1093/ajcp/aqv011
Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M, Zairis S, Gazaneo S,
De Falco G, Lazzi S, Bellan C, Rocca BJ, Amato T, Marasco E, Etebari M, Ogwang M, Calbi V, Ndede I, Patel K, Chumba D, Piccaluga PP, Pileri S, Leoncini L and Rabadan R (2015).
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. Public Library of Science (Plos) Plos Pathogens vol. 11, (10)
10.1371/journal.ppat.1005158
De Falco G, Ambrosio MR, Fuligni F, Onnis A, Bellan C, Rocca BJ, Navari M, Etebari M, Mundo L, Gazaneo S, Facchetti F, Pileri SA, Leoncini L and Piccaluga PP (2015).
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation. Springer Nature Bmc Cancer vol. 15, (1)
10.1186/s12885-015-1661-7
Ambrosio MR,
De Falco G, Rocca BJ, Barone A, Amato T, Bellan C, Lazzi S and Leoncini L (2015).
Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity. Virchows Archiv vol. 467, (4) 471-480.
10.1007/s00428-015-1814-8
Rogena EA, Simbiri KO,
De Falco G, Leoncini L, Ayers L and Nyagol J (2015).
A review of the pattern of AIDS defining, HIV associated neoplasms and premalignant lesions diagnosed from 2000–2011 at Kenyatta National Hospital, Kenya. Springer Nature Infectious Agents and Cancer vol. 10, (1)
10.1186/s13027-015-0021-1
Piccaluga PP, Navari M,
De Falco G, Ambrosio MR, Lazzi S, Fuligni F, Bellan C, Rossi M, Sapienza MR, Laginestra MA, Etebari M, Rogena EA, Tumwine L, Tripodo C, Gibellini D, Consiglio J, Croce CM, Pileri SA and Leoncini L (2015).
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas. Impact Journals Oncotarget vol. 7, (1) 224-240.
10.18632/oncotarget.4399
Hijazi K, Cuppone AM, Smith K, Stincarelli MA, Ekeruche-Makinde J,
De Falco G, Hold GL, Shattock R, Kelly CG, Pozzi G and Iannelli F (2015).
Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs. Public Library of Science (Plos) Plos One vol. 10, (6)
10.1371/journal.pone.0131405
Navari M, Etebari M,
De Falco G, Ambrosio MR, Gibellini D, Leoncini L and Piccaluga PP (2015).
The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma. Frontiers Frontiers in Microbiology vol. 6,
10.3389/fmicb.2015.00556
Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L,
De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M and Cesarman E (2015).
The tumor virus landscape of AIDS-related lymphomas. American Society of Hematology Blood vol. 125, (20) e14-e22.
10.1182/blood-2014-11-599951
Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C,
De Falco G, Ulivieri C, Ariani F, Mari F, Mencarelli MA, Hell JW, Renieri A and Meloni I (2015).
GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. European Journal of Human Genetics vol. 23, (2) 195-201.
10.1038/ejhg.2014.81
Rocca BJ, Ginori A, Barone A, Calandra C, Crivelli F,
De Falco G, Gazaneo S, Tripodi S, Cevenini G, del Vecchio MT, Ambrosio MR and Tosi P (2015).
Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment‐Related Changes. Hindawi Biomed Research International vol. 2015, (1)
10.1155/2015/985950
Ambrosio MR, Rocca BJ, Barone A, Onorati M, Mundo L, Crivelli F, Di Nuovo F,
De Falco G, del Vecchio MT, Tripodi SA and Tosi P (2015).
Expression of Translationally Controlled Tumor Protein in Human Kidney and in Renal Cell Carcinoma. Hindawi Biomed Research International vol. 2015, (1)
10.1155/2015/7303902014

Navari M, Fuligni F, Laginestra MA, Etebari M, Ambrosio MR, Sapienza MR, Rossi M,
De Falco G, Gibellini D, Tripodo C, Pileri SA, Leoncini L and Piccaluga PP (2014).
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Frontiers Frontiers in Microbiology vol. 5,
10.3389/fmicb.2014.00728
Luzzi A, Morettini F, Gazaneo S, Mundo L, Onnis A, Mannucci S, Rogena EA, Bellan C, Leoncini L and
De Falco G (2014).
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. Springer Nature Infectious Agents and Cancer vol. 9, (1)
10.1186/1750-9378-9-41
Ambrosio MR,
De Falco G, Gozzetti A, Rocca BJ, Amato T, Mourmouras V, Gazaneo S, Mundo L, Candi V, Piccaluga PP, Cusi MG, Leoncini L and Lazzi S (2014).
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. Haematologica vol. 99, (11) e235-e237.
10.3324/haematol.2014.111872
Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C,
De Falco G, Ulivieri C, Ariani F, Mari F, Mencarelli MA, Hell JW, Renieri A and Meloni I (2014).
GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. European Journal of Human Genetics 10.1038/ejhg.2014.81
Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C, Gomez G, Lazzi S, Piris MA, Leoncini L and
De Falco G (2014).
The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infectious Agents and Cancer vol. 9, (1)
10.1186/1750-9378-9-122013

Savino MT, Ulivieri C, Emmi G, Prisco D,
de Falco G, Ortensi B, Beccastrini E, Emmi L, Pelicci G, D'Elios MM and Baldari CT (2013).
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. Journal of Leukocyte Biology vol. 93, (4) 549-559.
10.1189/jlb.07123312012

Torricelli M, Novembri R, Conti N,
De Falco G, De Bonis M and Petraglia F (2012).
Correlation with placental kisspeptin in postterm pregnancy and apoptosis. Reproductive Sciences vol. 19, (10) 1133-1137.
10.1177/1933719112443878
Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M,
De Falco G, Calbi V, Ogwang M, Naresh KN, Pileri SA, Doglioni C, Leoncini L and Lazzi S (2012).
The Alteration of Lipid Metabolism in Burkitt Lymphoma Identifies a Novel Marker: Adipophilin. Plos One vol. 7, (8)
10.1371/journal.pone.0044315
Onnis A, Navari M, Antonicelli G, Morettini F, Mannucci S,
De Falco G, Vigorito E and Leoncini L (2012).
Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer Journal vol. 2, (8)
10.1038/bcj.2012.29
Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M, Cusi MG, Leoncini L, Van Den Bosch CA and
De Falco G (2012).
EBV reactivation and chromosomal polysomies: Euphorbia tirucalli as a possible cofactor in endemic Burkitt lymphoma. Advances in Hematology vol. 2012,
10.1155/2012/149780
Cozzi M, Giorgi F, Marcelli E, Pentimalli F, Forte IM, Schenone S, D'Urso V,
De Falco G, Botta M, Giordano A and Indovina P (2012).
Antitumor activity of new pyrazolo[3,4-d] pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition. Cell Cycle vol. 11, (5) 1029-1039.
10.4161/cc.11.5.195192011

Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T,
De Falco G, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM and Stein H (2011).
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia vol. 25, (12) 1869-1876.
10.1038/leu.2011.156
Rogena EA,
De Falco G, Schurfeld K and Leoncini L (2011).
A review of the trends of lymphomas in the equatorial belt of Africa. Hematological Oncology vol. 29, (3) 111-115.
10.1002/hon.977
Piccaluga PP,
De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C, Leucci E, Onnis A, Astolfi A, Sapienza MR, Bellan C, Lazzi S, Tumwine L, Mawanda M, Ogwang M, Calbi V, Formica S, Califano A, Pileri SA and Leoncini L (2011).
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood vol. 117, (13) 3596-3608.
10.1182/blood-2010-08-3015562010

Piccaluga PP,
De Falco G, Kustagi M, Gazzola A, Astolfi A, Agostinelli C, Leucci E, Onnis A, Tripodo C, Sapienza MR, Bellan C, Lazzi S, Tumwine L, Mawanda M, Ogwang M, Calbi V, Formica S, Califano A, Pileri S and Leoncini L (2010).
Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes. American Society of Hematology Blood vol. 116, (21)
10.1182/blood.v116.21.2494.2494
Onnis A,
De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S and Leoncini L (2010).
Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. Plos One vol. 5, (9)
10.1371/journal.pone.0012960
Capitani N, Lucherini OM, Sozzi E, Ferro M, Giommoni N, Finetti F,
De Falco G, Cencini E, Raspadori D, Pelicci PG, Lauria F, Forconi F and Baldari CT (2010).
Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia. Blood vol. 115, (18) 3726-3736.
10.1182/blood-2009-08-239244
Indovina P, Acquaviva A,
De Falco G, Rizzo V, Onnis A, Luzzi A, Giorgi F, Hadjistilianou T, Toti P, Tomei V, Pentimalli F, Carugi A and Giordano A (2010).
Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol vol. 223, (1) 143-150.
10.1002/jcp.22019
Leucci E, Onnis A, Cocco M,
De Falco G, Imperatore F, Giuseppina A, Costanzo V, Cerino G, Mannucci S, Cantisani R, Nyagol J, Mwanda W, Iriso R, Owang M, Schurfeld K, Bellan C, Lazzi S and Leoncini L (2010).
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. Int J Cancer vol. 126, (6) 1316-1326.
10.1002/ijc.24655
Carugi A, Onnis A, Antonicelli G, Rossi B, Mannucci S, Luzzi A, Lazzi S, Bellan C, Tosi GM, Sayed S,
De Falco G and Leoncini L (2010).
Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples. Hematol Oncol vol. 28, (1) 20-26.
10.1002/hon.9212009
De Falco G, Antonicelli G, Onnis A, Lazzi S, Bellan C and Leoncini L (2009).
Role of EBV in microRNA dysregulation in Burkitt lymphoma. Semin Cancer Biol vol. 19, (6) 401-406.
10.1016/j.semcancer.2009.07.003
Bellan C, Stefano L,
Giulia DF, Rogena EA and Lorenzo L (2009).
Burkitt lymphoma versus diffuse large B‐cell lymphoma: a practical approach. Wiley Hematological Oncology vol. 28, (2) 53-56.
10.1002/hon.916
Lazzi S, Bellan C, Onnis A,
De Falco G, Sayed S, Kostopoulos I, Onorati M, D'Amuri A, Santopietro R, Vindigni C, Fabbri A, Righi S, Pileri S, Tosi P and Leoncini L (2009).
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. Hum Pathol vol. 40, (9) 1252-1261.
10.1016/j.humpath.2009.01.007
Bellan C, Stefano L,
Giulia DF, Rogena EA and Lorenzo L (2009).
Burkitt lymphoma versus diffuse large B‐cell lymphoma: a practical approach. Wiley Hematological Oncology vol. 27, (4) 182-185.
10.1002/hon.9142008

Leucci E, Cocco M, Onnis A,
De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H and Leoncini L (2008).
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol vol. 216, (4) 440-450.
10.1002/path.2410
Giacinti C, Musarò A,
De Falco G, Jourdan I, Molinaro M, Bagella L, Simone C and Giordano A (2008).
Cdk9-55: a new player in muscle regeneration. J Cell Physiol vol. 216, (3) 576-582.
10.1002/jcp.21361
Nyagol J,
De Falco G, Lazzi S, Luzzi A, Cerino G, Shaheen S, Palummo N, Bellan C, Spina D and Leoncini L (2008).
HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas. J Hematop vol. 1, (1) 3-10.
10.1007/s12308-008-0002-z
De Falco G, Leucci E, Onnis A, Bellan C, Tigli C, Wirths S, Cerino G, Cocco M, Crupi D, De Luca A, Lanzavecchia A, Tosi P, Leoncini L and Giordano A (2008).
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells. J Cell Physiol vol. 215, (1) 276-282.
10.1002/jcp.213112007
De Falco G and Giordano A (2007).
Skin banks and the state of the art of research in Europe and United States. Rivista Italiana Di Chirurgia Plastica vol. 39, (3-4)

Bardelli M, Leucci E, Schürfeld K, Bellan C, Passiatore G, Rocchigiani M, Bartolommei S, Orlandini M, Zagursky J, Lazzi S,
De Falco G, Tosi P, Oliviero S and Leoncini L (2007).
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. Leuk Lymphoma vol. 48, (10) 2014-2021.
10.1080/10428190701540975
Torricelli M, Giovannelli A, Leucci E, Florio P,
De Falco G, Torres PB, Reis FM, Leoncini L and Petraglia F (2007).
Placental neurokinin B mRNA expression increases at preterm labor. Placenta vol. 28, (10) 1020-1023.
10.1016/j.placenta.2007.04.006
De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis A, Cerino G, Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H, Giordano A and Leoncini L (2007).
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. Blood vol. 110, (4) 1301-1307.
10.1182/blood-2006-12-064865
Leucci E,
De Falco G, Onnis A, Cerino G, Cocco M, Luzzi A, Crupi D, Tigli C, Bellan C, Tosi P, Leoncini L and Giordano A (2007).
The role of the Cdk9/Cyclin T1 complex in T cell differentiation. J Cell Physiol vol. 212, (2) 411-415.
10.1002/jcp.21032
Roviello F, Corso G, Pedrazzani C, Marrelli D,
De Falco G, Berardi A, Garosi L, Suriano G, Vindigni C, De Stefano A, Leoncini L, Seruca R and Pinto E (2007).
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol vol. 33, (4) 448-451.
10.1016/j.ejso.2006.10.028
Torricelli M, Giovannelli A, Leucci E,
De Falco G, Reis FM, Imperatore A, Florio P and Petraglia F (2007).
Labor (term and preterm) is associated with changes in the placental mRNA expression of corticotrophin-releasing factor. Reprod Sci vol. 14, (3) 241-245.
10.1177/1933719107300971
Leucci E, Onnis A,
De Falco G, Luzzi A, Cerino G, Giordano A and Leoncini L (2007).
Silencing human Rb2/p130 with shRNA. Cell Oncol vol. 29, (3) 265-268.
10.1155/2007/438684
Roviello F, Corso G, Pedrazzani C, Marrelli D,
De Falco G, Suriano G, Vindigni C, Berardi A, Garosi L, De Stefano A, Leoncini L, Seruca R and Pinto E (2007).
High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology vol. 72, (3-4) 243-247.
10.1159/000113015
Torricelli M,
De Falco G, Florio P, Rossi M, Leucci E, Viganò P, Leoncini L and Petraglia F (2007).
Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Hum Reprod vol. 22, (1) 92-96.
10.1093/humrep/del3312006

Florio P, Torricelli M,
De Falco G, Leucci E, Giovannelli A, Gazzolo D, Severi FM, Bagnoli F, Leoncini L, Linton EA and Petraglia F (2006).
High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. J Hypertens vol. 24, (9) 1831-1840.
10.1097/01.hjh.0000242408.65783.b2
Caracciolo V, Reiss K, Khalili K,
De Falco G and Giordano A (2006).
Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene vol. 25, (38) 5294-5301.
10.1038/sj.onc.1209681
De Falco G, Comes F and Simone C (2006).
pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription. Oncogene vol. 25, (38) 5244-5249.
10.1038/sj.onc.1209623
Florio P,
De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, Dell'Anna A, Tiso E, Santopietro R, Leoncini L and Petraglia F (2006).
Urocortin expression is downregulated in human endometrial carcinoma. J Endocrinol vol. 190, (1) 99-105.
10.1677/joe.1.06726
Nyagol J, Leucci E, Onnis A,
De Falco G, Tigli C, Sanseverino F, Torriccelli M, Palummo N, Pacenti L, Santopietro R, Spina D, Gichangi P, Muchiri L, Lazzi S, Petraglia F, Leoncini L and Giordano A (2006).
The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther vol. 5, (6) 684-690.
10.4161/cbt.5.6.2907
Vogiatzi P,
De Falco G, Claudio PP and Giordano A (2006).
How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions. Cancer Biol Ther vol. 5, (4) 371-374.
10.4161/cbt.5.4.27482005

Vogiatzi P and
De Falco G (2005).
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Women's Oncology Review vol. 5, (4) 219-221.
10.1080/14733400500422008
Florio P, Torricelli M, Galleri L,
De Falco G, Leucci E, Calonaci G, Picciolini E, Ambrosini G, Linton EA and Petraglia F (2005).
High fetal urocortin levels at term and preterm labor. J Clin Endocr Metab vol. 90, (9) 5361-5365.
10.1210/jc.2005-0109
De Falco G, Bellan C, D'Amuri A, Angeloni G, Leucci E, Giordano A and Leoncini L (2005).
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors. Cancer Biol Ther vol. 4, (3) 277-281.
10.4161/cbt.4.3.14972004

Bellan C,
De Falco G, Lazzi S, Micheli P, Vicidomini S, Schürfeld K, Amato T, Palumbo A, Bagella L, Sabattini E, Bartolommei S, Hummel M, Pileri S, Tosi P, Leoncini L and Giordano A (2004).
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. J Pathol vol. 203, (4) 946-952.
10.1002/path.15882003
De Falco G, Bellan C, Lazzi S, Claudio P, La Sala D, Cinti C, Tosi P, Giordano A and Leoncini L (2003).
Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene vol. 22, (40) 6214-6219.
10.1038/sj.onc.1206637
Bellan C, Lazzi S,
De Falco G, Nyongo A, Giordano A and Leoncini L (2003).
Burkitt's lymphoma: new insights into molecular pathogenesis. J Clin Pathol vol. 56, (3) 188-192.
10.1136/jcp.56.3.1882002

Bellan C,
De Falco G, Tosi GM, Lazzi S, Ferrari F, Morbini G, Bartolomei S, Toti P, Mangiavacchi P, Cevenini G, Trimarchi C, Cinti C, Giordano A, Leoncini L, Tosi P and Cottier H (2002).
Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. Invest Ophthalmol Vis Sci vol. 43, (12) 3602-3608.

Lazzi S, Bellan C,
De Falco G, Cinti C, Ferrari F, Nyongo A, Claudio PP, Tosi GM, Vatti R, Gloghini A, Carbone A, Giordano A, Leoncini L and Tosi P (2002).
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis. Hum Pathol vol. 33, (7) 723-731.
10.1053/hupa.2002.125372
Simone C, Stiegler P, Bagella L, Pucci B, Bellan C,
De Falco G, De Luca A, Guanti G, Puri PL and Giordano A (2002).
Activation of MyoD-dependent transcription by cdk9/cyclin T2. Oncogene vol. 21, (26) 4137-4148.
10.1038/sj.onc.1205493
De Falco G and Giordano A (2002).
CDK9: From basal transcription to cancer and AIDS. Cancer Biology & Therapy vol. 1, (4) 342-347.
De Falco G, Maria Neri L, De Falco M, Bellan C, Yu Z, De Luca A, Leoncini L and Giordano A (2002).
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines. Oncogene vol. 21, (49) 7464-7470.
10.1038/sj.onc.12059672001

Zini N, Trimarchi C, Claudio PP, Stiegler P, Marinelli F, Maltarello MC, La Sala D,
De Falco G, Russo G, Ammirati G, Maraldi NM, Giordano A and Cinti C (2001).
pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus. J Cell Physiol vol. 189, (1) 34-44.
10.1002/jcp.1135
De Falco M, Laforgia V, Fedele V, De Luca L, Cottone G,
De Falco G and De Luca A (2001).
Vasoactive intestinal peptide stimulation modulates the expression of Bcl-2 family members in the adrenal gland of the lizard Podarcis sicula. Histochem J vol. 33, (11-12) 639-645.
10.1023/a:10163024009962000
De Falco G, Bagella L, Claudio PP, De Luca A, Fu Y, Calabretta B, Sala A and Giordano A (2000).
Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation. Oncogene vol. 19, (3) 373-379.
10.1038/sj.onc.12033051999
1998
1997

Giordano V,
De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, Delmastro P, Gadina M and Scala G (1997).
Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. J Immunol vol. 158, (9) 4097-4103.
10.4049/jimmunol.158.9.40971996

Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M,
De Falco G, Palmieri C, Franzoso G, Quinto I, Venuta S and Scala G (1996).
Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors. J Biol Chem vol. 271, (37) 22479-22486.
10.1074/jbc.271.37.22479